Home Featured

Featured

Random

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

PharmaTher Announces Sale of Psilocybin Program

atai Life Sciences Announces Launch of Initial Public Offering

PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder...

The Compounds in Psychedelic Cacti

MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD...

Senior Program Director

The Benefits of Mescaline: How An Ancient Cactus Became a Future...

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment...

PT239 – Richie Ogulnick – Ibogaine, Unicity, and Beneficence

MindMed To Commence Trading on Nasdaq

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in...

The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for...

12 3...141 Page 1 of 141

EDITOR PICKS

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of...

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual...

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Having Sex on DMT: What You Need to Know

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.